Overview

A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate Racivir. The safety, most effective dosage, and how the body reacts to Racivir will be studied.
Phase:
Phase 1
Details
Lead Sponsor:
Pharmasset
Treatments:
Racivir